Upregulation Of Mir-21 Restores Cardioprotection Under Diabetic Conditions

jessica olson,yasheng yan,xiaowen bai,mingyu liang,zeljko j bosnjak

DOI: https://doi.org/10.1096/fasebj.29.1_supplement.1040.2

2015-01-01

Abstract:Introduction Anesthetic preconditioning (APC) has been shown to decrease myocardial infarct size following ischemia reperfusion injury. This protective effect is attenuated under diabetic conditions, but the underlying mechanisms are largely unknown. MicroRNAs are short, non‐coding nucleotide sequences that suppress and degrade mRNA. Previously, we have shown the functional role of miR‐21 as a novel mediator of APC. Now, we show for the first time its role in attenuated protection seen in diabetic conditions. We hypothesized that upregulation of miR‐21 would restore cardiac protection in animal and human models of diabetes . Methods Attenuated APC was investigated in the db/db mouse, the T2DN rat, and in diabetic patient‐derived cardiomyocytes. miR‐21 expression was analyzed using qRT‐PCR and manipulated using GFP‐tagged mimics and antagomirs. Protein expression was examined via Western blot, and cell viability was assessed by propidium iodide staining. Results In non‐diabetic models, isoflurane exposure caused a cardioprotective response. This response was abolished in diabetic models, as well as after knockdown of miR‐21. Diabetic models exhibited lower baseline levels of miR‐21 and a significant decrease in expression levels after exposure to isoflurane. This cardioprotective effect was restored using adenoviral‐mediated upregulation of miR‐21. Conclusions Our results indicate an important role of miR‐21 in the impairment of APC under diabetic conditions. Further investigation into this phenomenon may suggest new therapeutic targets for reducing perioperative cardiovascular morbidity and mortality in both healthy and diabetic patients.